Rockwell Medical Technologies, Inc. manufactures, sells and distributes hemodialysis concentrate solutions and dialysis kits. The Company sells, distributes and delivers these and other ancillary hemodialysis products primarily to hemodialysis providers in the United States, as well as internationally primarily in Latin America, Asia and Europe. Hemodialysis duplicates kidney function in patients with failing kidneys also known as End Stage Renal Disease (ESRD). Hemodialysis concentrates comprises two primary product types, which are described as acidified dialysate concentrate, also known as acid concentrate, and bicarbonate. The Company’s dialysis solutions (also known as dialysate) are used to maintain life, removing toxins and replacing nutrients in the dialysis patient’s bloodstream. Rockwell Medical Technologies, Inc. has licensed and is developing renal drug therapies for both iron-delivery and carnitine/vitamin-delivery, utilizing dialysate as the delivery mechanism.